Life Extension (September 2003) published an article by Sergey A. Dzugan, PhD, and R. Arnold Smith, MD, that proposes that hypercholesterolemia is the result of a multihormone deficiency. The body uses cholesterol as a basic component of cell membranes, bile acids, vitamin D3, and as the precursor to steroidal hormones such as pregnenolone, DHEA, testosterone, progesterone. The authors propose that the body responds to a deficiency of these hormones by overproducing cholesterol.
To test their hypothesis, the doctors performed a clinical study from July 1997 to April 2003, involving 41 patients with high cholesterol levels. The patients, ages 25 to 81, received combinations of multiple humanidentical hormones. "If even one steroidal hormone is left out, then the body may respond to this deficiency by synthesizing more steroidal hormonal precursor, (i.e. cholesterol)," the authors explain. The hormones were given in individualized, physiologic ratios, designed to produce "youthful physiologic (not 'normal') serum levels." The doctors determined each patient's dosage by periodically measuring serum hormone levels. Dose schedules simulated natural human production cycles.
All 41 patients responded to the therapy. Mean serum total cholesterol decreased from a baseline of 254.6 mg/dL to 188.8 mg/dL after treatment, a decrease of 25.6%. Serum HDL levels (the lipoprotein that scavenges free cholesterol and transports it back to the liver) also dropped (19.6%), "but remained much higher than undesirable levels in all cases." The authors view the decrease in HDL as a sign that cholesterol levels had normalized and that extra HDL was unnecessary. The doctors also noticed that the multiple steroid hormone therapy had improved thyroid function. All patients reported a "significant improvement in quality of life."
Dzugan, Sergey A., PhD. & Smith, R. Arnold, MD. Treating High Cholesterol by Replacing Hormones Lost to Aging. Life Extension September 2003
COPYRIGHT 2004 The Townsend Letter Group
COPYRIGHT 2004 Gale Group